Head of Growth

About Third Wave Third Wave educates the public on the importance of responsible and intentional psychedelic use. Our mission is to facilitate the world’s adoption of psychedelics as useful tools for healing and transformation. We do this through well-researched online content that is widely accessible and well-branded. Currently, we reach over 300K people per month, and have been featured in the BBC, Forbes, and the New York Times. With the rapid growth of interest in […]

Read more
Lead Editor

As the psychedelic renaissance gains momentum, the demand for high-quality financial reports detailing this space is greater than ever. Microdose and The Conscious Fund are excited to announce our upcoming investment grade intelligence guide to the psychedelic sector–and we need your help! We are looking to bring a Lead Editor on board to assist us in the completion of this project. The report has already been drafted by more than a dozen expert contributors and […]

Read more
Business Associate

ATAI is a Berlin, New York, and London based biotech company builder leveraging a decentralized, data-driven platform model with the aim of ultimately healing mental health disorders. We are dedicated to bringing innovation to mental healthcare, a field that has seen little progress since the development of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) in the 1980s and 1990s, respectively.  Our portfolio companies are developing innovative solutions in mental healthcare, including COMPASS Pathways […]

Read more
Internship – Business Operations

ATAI is a Berlin, New York, and London based biotech company builder leveraging a decentralized, data-driven platform model with the aim of ultimately healing mental health disorders. We are dedicated to bringing innovation to mental healthcare, a field that has seen little progress since the development of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) in the 1980s and 1990s, respectively.  Our portfolio companies are developing innovative solutions in mental healthcare, including COMPASS Pathways […]

Read more
Working Student – Business Operations

ATAI is a Berlin, New York, and London based biotech company builder leveraging a decentralized, data-driven platform model with the aim of ultimately healing mental health disorders. We are dedicated to bringing innovation to mental healthcare, a field that has seen little progress since the development of selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) in the 1980s and 1990s, respectively.  Our portfolio companies are developing innovative solutions in mental healthcare, including COMPASS Pathways […]

Read more